The prognostic significance of p34(cdc2) and cyclin D1 protein expression in prostate adenocarcinoma

Cancer

Volumn 80, Issue 4, 1997, Pages 753-763

  Kallakury, Bhaskar V S ^a   Sheehan, Christine E ^a   Ambros, Robert A ^a   Fisher, Hugh A G ^a   Kaufman Jr , Ronald P ^a   Ross, Jeffrey S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Adenocarcinoma; Cyclin D1; Immunohistochemistry; p34(cdc2); prognosis; Prostate

Indexed keywords

CYCLIN D1; PROTEIN KINASE; CYCLIN DEPENDENT KINASE 1; CYCLINE; DNA; ONCOPROTEIN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DNA CONTENT; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; ADENOCARCINOMA; AGED; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PLOIDY; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CDC2 PROTEIN KINASE; CYCLIN D1; CYCLINS; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOGENE PROTEINS; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030611850     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970815)80:4<753::AID-CNCR15>3.0.CO;2-S     Document Type: Article

References (81)

1. 1 cyclins. Cell 1992;71:323-34.
2. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
3. Dunphy WG. The decision to enter mitoses. Trends Cell Biol 1994;4:202-7.
4. Norbury C, Nurse P. Animal cell cycles and their control. Ann Rev Biochem 1992;61:441-70.
5. 1 to S-phase transition. Ann Rev Cell Biol 1992;8:529-61.
6. Nasmyth K. Control of yeast cell cycle by the Cdc 28 protein kinase. Curr Opin Cell Biol 1993;5:166-79.
7. cdc2 in the cells of normal, hyperplastic, and malignant epithelial and lymphoid tissues of the oral cavity. J Pathol 1996;178:422-8.
8. 2 for control of mitosis in fission yeast. Nature 1981;292:558-60.
9. Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell-cycle-dependent phosphorylation and subunit rearrangement. Cell 1988;54:17-26.
10. Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D. Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell 1989;56:829-38.
11. Gautier J, Minshull J, Lohka M, Hunt T, Maller J. Cyclin is a component of MPF from xenopus. Cell 1990;60:487-94.
12. Labbe JC, Capony JP, Caput D, Cavadore JC, Derancourt J, Kaghad M, et al.. MPF from starfish oocytes at first meiotic metaphase is a heterodimer containing one molecule of cdc2 and one molecule of cyclin B. EMBO J 1989;8:3053-8.
13. Fesquet D, Labbe JC, Derancourt J. Capony JP, Galas S, Girard F, et al., The MO 15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr 161 and its homologues. EMBO J 1993;12:3111-21.
14. Poon RY, Yamashita K, Adamczewski JP, Hunt T, Shuttleworth J. The cdc2-related protein p40 MO15 is the catalyctic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J 1993;12:3123-32.
15. Solomon MJ, Harper JW, Shuttleworth J. CAK, the p34cdc2 activating kinase contains a protein identical or closely related to p40 MO15. EMBO J 1993;12:3133-42.
16. Draetta G, Piwnica-Worms H, Morrison D, Druker B, Roberts T, Beach D. Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate. Nature 1988;336:738-44.
17. Fleig UN, Gould KL. Regulation of cdc2 activity in Schizosaccharomyces pombe: the role of phosphorylation. Semin Cell Biol 1991;2:195-204.
18. Gabrielli BG, Lee MS, Walker DH, Piwnica-Worms H, Maller JL. Cdc 25 regulates the phosphorylation and activity of the xenopus cdk2 protein kinase complex. J Biol Chem 1992; 267:18040-6.
19. Gould KL, Nurse P. Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 1989;342:39-45.
20. Krek W, Nigg EA. Cell cycle regulation of vertebrate p34cdc2 activity: identification of Thr 161 as an essential in vivo phosphorylation site. New Biol 1992;4:323-9.
21. Kumagai A, Dunphy WG. Molecular mechanism of the final steps in the activation of MPF. Cold Spring Harb Symp Quant Biol 1991;56:585-9.
22. Morla AO, Draetta G, Beach D, Wang JY. Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis. Cell 1989;58:193-203.
23. Nigg EA, Gallant P, Krek W. Regulation of p34 cdc2 protein kinase activity by phosphorylation and cyclin binding. Ciba Found Symp 1992;170:72-84.
24. Parker L, Piwnica-Worms H. Inactivation of the p34 cdc2-cyclin B complex of the human WEE1 tyrosine kinase. Science 1992;257:1955-7.
25. Hamaguchi JR, Tobey RA, Pines J, Crissman HA, Hunter T, Bradbury EM. Requirement for p34 cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210. J Cell Biol 1992;117:1041-53.
26. Lehner CF, O'Farrell PH. Expression and function of Drosophilia cyclin A during embryonic cell cycle progression. Cell 1989;56:957-68.
27. Lehner CF, O'Farrell PH. Drosophilia cdc2 homologs: a functional homolog is co-expressed with a cognate variant. EMBO J 1990;9:3573-81.
28. Lehner CF, O'Farrell PH. The roles of Drosphilia cyclins A andBin mitotic control. Cell 1990;61:535-47.
29. O'Farrell PH, Edgar BA, Lakich D, Lehner CF. Directing cell division during development. Science 1989:246:635-40.
30. Doussis-Anagostopoulou IA, Tennant RC, Gannon J, Gatter KC. Distribution of the cdc2 gene product in normal tissues: an immunocytochemical study using four new monoclonal antibodies. Histopathology 1994;24:335-40.
31. Welch PJ, Wang JYJ. Coordinated synthesis and degradation of cdc2 in the mammalial cell cycle. Proc Natl Acad Sci U S A 1992;89:3093-7.
32. Krek W, Nigg EA. Structure and developmental expression of the chicken cdc2 kinase. EMBO J 1989;8:3071-8.
33. Lee MG, Norbury CJ, Spurr NK, Nurse P. Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein. Nature 1988;333:676-9.
34. Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J, et al. . Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993; 121:101-11.
35. Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, Ito H, et al. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 1993;53:36-41.
36. Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 1991;66:1197-1206.
37. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991:65:701-13.
38. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991;65:691-9.
39. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991;350:512-5.
40. Arnold A, Motokura T, Bloom T, Kronenberg H, Ruderman J, Juppner H, et al. The putative oncogene PRAD1 encodes a novel cyclin. Cold Spring Harb Symp Quant Biol 1991;56:93-7.
41. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991;88:9638-42.
42. Medeiros LJ, Van Krienken JH, Jaffe ES, Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 1990;76:2086-90.
43. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 1991; 78:493-8.
44. Raffeld M, Jaffe ES. BCL-1 t(11:14), and mantle cell-derived lymphoma. Blood 1991;78:259-63.
45. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, et al. Cyelin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 1995;8:560-7.
46. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992;52:2980-3.
47. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bel-1 locus in head and neck squamous cell carcinomas. Oncogene 1989;4:1111-6.
48. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993;196:10-6.
49. Berenson JR, Koga H, Yang J, Pearl J, Holmes EC, Figlin R, et al. Frequent amplification of the BCL-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene 1990;5:1343-8.
50. Motokura T, Arnold A. Cyclins and oncogenesis. Biochem Biophys Acta 1993;1155:63-78.
51. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrently accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775-8.
52. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992;23:273-9.
53. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave overheating of tissue sections. J Histochem Cytochem 1991;39:741-8.
54. Ross JS, Nazeer T, Church K, Amato C, Figge H, Rifkin MD, et al. Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the < prediction of prostatic carcinoma metastasis. Cancer 1993;72:3020-8.
55. Cox DR. Regression models in life tables. J R Stat Soc 1972;32:187-98.
56. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1957;53:457-81.
57. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330: 242-8.
58. Jones GW. Prospective, conservative management of localized prostate cancer. Cancer 1992;70:307-10.
59. Riabowol K, Draetta G, Brizuela L, Vandre D, Beach D. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 1989;57:393-401.
60. Th'ng JPH, Wright PS, Hamaguchi J, Lee MG, Norbury CJ, Nurse T, et al. The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell 1990;63:313-24.
61. Fang F, Newport JW. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 1991;66:731-42.
62. Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, et al. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 1995;71:1231-6.
63. Ross JS, Sheehan C, Hayner-Buchnan AM, Ambros RA, Kallakury BVS, Kaufman R, et al. HER-2/neu oncogene amplification status in prostate cancer by fluorescence in-situ hybridization. Hum Pathol. In press.
64. Kallakury BVS, Figge J, Ross JS, Fisher HAG, Figge HL, Jennings TA. Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma. Hum Pathol 1994;25:92-7.
65. Kallakury BVS, Yang F, Figge J, Smith KE, Kausik SJ, Tacy NJ, et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy. Cancer 1996;78:1461-9.
66. Ross JS, Figge HL, Bui HX, del Rosario AD, Fisher HAG, Nazeer T, et al. E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome. Mod Pathol 1994, 7:835-41.
67. 2/M and enters vesicles at anaphase. EMBO J 1989;8:3985-95.
68. Heald R, McLoughlin M, McKeon F. Human wee 1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 1993;74:463-74.
69. Pines J, Hunter T. Human cyclins A and B1 are differently located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 1991;115:1-17.
70. Akhurst RJ, Flavin NB, Worden J, Lee MG. Intracellular localisation and expression of mammalial CDC2 protein during myogenic differentiation. Differentiation 1989;40:36-41.
71. cdc2-Cyclin B complex at meiosis: reinitiation in starfish oocytes, EMBO J 1992;11:1763-72.
72. Elledge SJ, Richman R, Hall FL, Williams RT, Lodgson N, Harper JW. CDK2 encodes a 33-kDa cyclin A associated protein kinase and is expressed before CDC2 in the cell cycle. Proc Natl Acad Sci U S A 1992;89:2907-11.
73. 2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci U S A 1992;89:2824-8.
74. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992;257:1689-94.
75. Williams RT, Wu L, Carbonaro-Hall DA, Tolo VT, Hall FL. Identification of a novel cyclin-like protein in human tumor cells. J Biol Chem 1993;268:8871-80.
76. Hall FL, Williams RT, Wu L, Wu F, Carbonaro-Hall DA, Harpar JW, et al. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein. Oncogene 1993;8:1377-84.
77. Quelle DE, Ashmun RA, Shurtleff SA, Kalo J, Bar-Sagi D, Roussel M, et al. Over-expression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993;7:1559-71.
78. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-61.
79. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-71.
80. Frierson HF, Gaffey MJ, Zukerberg LR, Arnold A, Williams ME. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod Pathol 1996;9:725-30.
81. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-9.